Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more.

Sanofi is the largest biopharma manufacturer in Canada, and the only company investing, innovating and operating across the full life sciences value chain. We are 2,000+ employees strong, invest 20% of our revenue annually in biopharma research, and are on track to deliver over $2 billion in new infrastructure investments by 2028.

We are focused on developing and delivering life-changing medicines and vaccines for many of the world’s most complex diseases, including in areas such as respiratory, neurology, dermatology, oncology, autoimmune diseases, rare diseases and more.  Our pioneering research into the immune system addresses the drivers of human health to improve how we treat and prevent diseases, and ensure our medicines and vaccines reach the patients who need them most, as fast as possible.